Page 15 - Aurobindo Pharma

Aurobindo gets US nod for seizures treatment drug

The company is eligible for 180 days of generic drug shared exclusivity

Aurobindo Pharma gets USFDA nod for two drugs

Heartburn relief medicine Famotidine tablets is expected to be launched in the second quarter of 2016-17

Aurobindo Pharma gains on USFDA nod for hypertension drug

The USFDA has approved manufacture and market Amlodipine and Valsartan tablets USP

Aurobindo Pharma gains on USFDA nod for gastroesophageal reflux drug

The USFDA nod is for Esomeprazole Magnesium delayed-release capsules USP in dosages of 20mg and 40mg.

Aurobindo Pharma gets USFDA nod for gastro reflux drug

The drug major said that the launch of the product is based on the settlement terms with AstraZeneca.

Aurobindo gets USFDA final nod for generic Nexium

The approved drug has an estimated market size of $4.2 billion for twelve months ending February, 2016

Aurobindo gets US FDA nod for gastrointestinal drug

This product is expected to be launched in the first quarter of FY17

Aurobindo Pharma gets final USFDA nod for gastro reflux drug

The firm said this product is expected to be launched in the first quarter of next fiscal

Aurobindo Pharma gets USFDA nod for antibiotic drug

The company will launch its antibiotic drug Vancomycin Hydrochloride in the later part of FY16-17

Aurobindo Pharma gets FDA nod for Alzheimer's, Parkinson's drug

The approved product has an estimated market size of $26.7 million for the 12 months ending January 2016

Aurobindo Pharma gains on USFDA nod for Naproxen Sodium Tablets

The approved product has an estimated market size of US $96 million for 12 months ended January 2016, according to IMS.

Aurobindo Pharma gets final nod for osteoporosis drug

Ibandronate Sodium tablets are used in the treatment and prevention of osteoporosis in postmenopausal women

Aurobindo gets USFDA nod for antidote to pain-killer drug overdose

The product is expected to be launched in the first quarter of the next fiscal

Aurobindo Pharma surges on USFDA nod for anti-HIV tablets

The stock rallied 6% to Rs 649 on USFDA nod for Ritonavir tablets

Aurobindo Pharma gets US FDA nod for anti-HIV tablets

The company's Ritonavir tablets in the strength of 100 mg got the health regulator's tentative approval